Literature DB >> 8297373

Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy.

A Uchiyama1, Y Suzuki, X Q Song, T Fukao, A Imamura, S Tomatsu, N Shimozawa, N Kondo, T Orii.   

Abstract

The molecular basis of X-linked adrenoleukodystrophy (ALD) was investigated. Six (A to 50) fragments of cDNA for ALD protein (Mosser et al. Nature 361: 726-730, 1993) from an adult patient with adrenomyeloneuropathy were amplified by PCR and mutations were screened by Mutation Detection Enhancement gel electrophoresis. A single base substitution (2154 C-->T, which resulted in the formation of a termination codon for glutamine (Q590STOP) and deletes Pst I site (CTGCAG-->CTGTAG), was detected. Eight other ALD patients did not have this mutation. A family study revealed the presence of both the mutant and normal alleles in the mother, a sister and a niece, indicating that these individuals were carriers. A nephew with childhood ALD who died 10 years earlier had the same mutant allele as detected by Pst I restriction assay. This report is the first description of a mutant allele for ALD, at the cDNA level, and presents confirmatory evidence of ALD protein as the primary etiology of ALD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297373     DOI: 10.1006/bbrc.1994.1092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  X-linked adrenoleukodystrophy: genes, mutations, and phenotypes.

Authors:  K D Smith; S Kemp; L T Braiterman; J F Lu; H M Wei; M Geraghty; G Stetten; J S Bergin; J Pevsner; P A Watkins
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.

Authors:  V Feigenbaum; G Lombard-Platet; S Guidoux; C O Sarde; J L Mandel; P Aubourg
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 3.  DNA diagnosis of X-linked adrenoleukodystrophy.

Authors:  S Seneca; W Lissens
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy.

Authors:  Y Suzuki; K Isogai; T Teramoto; H Tashita; N Shimozawa; M Nishimura; T Asano; M Oda; A Kamei; H Ishiguro; S Kato; T Ohashi; H Kobayashi; Y Eto; N Kondo
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

5.  Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.

Authors:  N Cartier; J Lopez; P Moullier; F Rocchiccioli; M O Rolland; P Jorge; J Mosser; J L Mandel; P F Bougnères; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.

Authors:  A Braun; H Ambach; S Kammerer; B Rolinski; S Stöckler; W Rabl; J Gärtner; S Zierz; A A Roscher
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

7.  Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein.

Authors:  M J Ligtenberg; S Kemp; C O Sarde; B M van Geel; W J Kleijer; P G Barth; J L Mandel; B A van Oost; P A Bolhuis
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy.

Authors:  E W Krasemann; V Meier; G C Korenke; D H Hunneman; F Hanefeld
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

9.  Altered expression of ALDP in X-linked adrenoleukodystrophy.

Authors:  P A Watkins; S J Gould; M A Smith; L T Braiterman; H M Wei; F Kok; A B Moser; H W Moser; K D Smith
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

10.  De novo missense mutation Y174S in exon 1 of the adrenoleukodystrophy (ALD) gene.

Authors:  A Barceló; M Girós; C O Sarde; G Pintos; J L Mandel; T Pàmpols; X Estivill
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.